A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors TTY Biopharm
- 11 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 08 May 2014 Planned end date changed from 1 Dec 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 18 Jun 2013 New trial record